CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $16,143,000 | +2.7% | 878,324 | +2.4% | 0.00% | 0.0% |
| Q3 2020 | $15,724,000 | +22.3% | 857,334 | -0.1% | 0.00% | 0.0% |
| Q2 2020 | $12,852,000 | +1.0% | 858,590 | +6.7% | 0.00% | 0.0% |
| Q1 2020 | $12,725,000 | -3.3% | 804,372 | -0.7% | 0.00% | 0.0% |
| Q4 2019 | $13,156,000 | +13.9% | 810,082 | +4.2% | 0.00% | – |
| Q3 2019 | $11,551,000 | -6.8% | 777,362 | +3.7% | 0.00% | -100.0% |
| Q2 2019 | $12,394,000 | +10.9% | 749,694 | +16.0% | 0.00% | – |
| Q1 2019 | $11,179,000 | -3.8% | 646,154 | -1.8% | 0.00% | -100.0% |
| Q4 2018 | $11,620,000 | +1.0% | 657,998 | +3.8% | 0.00% | – |
| Q3 2018 | $11,508,000 | -0.0% | 634,006 | +7.7% | 0.00% | -100.0% |
| Q2 2018 | $11,512,000 | +632.3% | 588,852 | +557.1% | 0.00% | – |
| Q1 2018 | $1,572,000 | +53.1% | 89,615 | -1.9% | 0.00% | – |
| Q4 2017 | $1,027,000 | +5.5% | 91,332 | -0.1% | 0.00% | – |
| Q3 2017 | $973,000 | +20.1% | 91,422 | -1.2% | 0.00% | – |
| Q2 2017 | $810,000 | -88.6% | 92,508 | -84.7% | 0.00% | – |
| Q1 2017 | $7,124,000 | +32281.8% | 603,651 | +35098.3% | 0.00% | – |
| Q4 2016 | $22,000 | -18.5% | 1,715 | -6.0% | 0.00% | – |
| Q3 2016 | $27,000 | +42.1% | 1,824 | +16.8% | 0.00% | – |
| Q2 2016 | $19,000 | +58.3% | 1,562 | +159.0% | 0.00% | – |
| Q1 2016 | $12,000 | +140.0% | 603 | +149.2% | 0.00% | – |
| Q4 2015 | $5,000 | +25.0% | 242 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | -55.6% | 242 | 0.0% | 0.00% | – |
| Q2 2015 | $9,000 | – | 242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|